Fan Yujie,Qu Shuangquan.Research advances of NLRP3 inflammasome in lung injury[J].Journal of Clinical Pediatric Surgery,,():288-292.[doi:10.3760/cma.j.cn101785-202311050-017]
Click Copy

Research advances of NLRP3 inflammasome in lung injury

References:

[1] Herrlich A.Interorgan crosstalk mechanisms in disease:the case of acute kidney injury-induced remote lung injury[J].FEBS Lett,2022,596(5):620-637.DOI:10.1002/1873-3468.14262.
[2] Wang ZH,Pu QQ,Huang CH,et al.Crosstalk between lung and extrapulmonary organs in infection and inflammation[J].Adv Exp Med Biol,2021,1303:333-350.DOI:10.1007/978-3-030-63046-1_18.
[3] Zhong WJ,Liu T,Yang HH,et al.TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury[J].Int J Biol Sci,2023,19(1):242-257.DOI:10.7150/ijbs.77304.
[4] Coll RC,Schroder K,Pelegrín P.NLRP3 and pyroptosis blockers for treating inflammatory diseases[J].Trends Pharmacol Sci,2022,43(8):653-668.DOI:10.1016/j.tips.2022.04.003.
[5] Seoane PI,Lee B,Hoyle C,et al.The NLRP3-inflammasome as a sensor of organelle dysfunction[J].J Cell Biol,2020,219(12):e202006194.DOI:10.1083/jcb.202006194.
[6] Swanson KV,Deng M,Ting JPY.The NLRP3 inflammasome:molecular activation and regulation to therapeutics[J].Nat Rev Immunol,2019,19(8):477-489.DOI:10.1038/s41577-019-0165-0.
[7] Lee S,Suh GY,Ryter SW,et al.Regulation and function of the nucleotide binding domain leucine-rich repeat-containing receptor,pyrin domain-containing-3 inflammasome in lung disease[J].Am J Respir Cell Mol Biol,2016,54(2):151-160.DOI:10.1165/rcmb.2015-0231TR.
[8] Zheng DP,Liwinski T,Elinav E.Inflammasome activation and regulation:toward a better understanding of complex mechanisms[J].Cell Discov,2020,6(1):36.DOI:10.1038/s41421-020-0167-x.
[9] Lu FF,Lan ZX,Xin ZQ,et al.Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases[J].J Cell Physiol,2020,235(4):3207-3221.DOI:10.1002/jcp.29268.
[10] Hoffman KW,Visoki E,Argabright ST,et al.Association between asthma and suicidality in 9-12-year-old youths[J].Brain Sci,2022,12(12):1602.DOI:10.3390/brainsci12121602.
[11] Leszczyńska K,Jakubczyk D,Górska S.The NLRP3 inflammasome as a new target in respiratory disorders treatment[J].Front Immunol,2022,13:1006654.DOI:10.3389/fimmu.2022.1006654.
[12] Hikichi M,Mizumura K,Maruoka S,et al.Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke[J].J Thorac Dis,2019,11(Suppl 17):S2129-S2140.DOI:10.21037/jtd.2019.10.43.
[13] Guo P,Li R,Piao TH,et al.Pathological mechanism and targeted drugs of COPD[J].Int J Chron Obstruct Pulmon Dis,2022,17:1565-1575.DOI:10.2147/COPD.S366126.
[14] Liu G,Philp AM,Corte T,et al.Therapeutic targets in lung tissue remodelling and fibrosis[J].Pharmacol Ther,2021,225:107839.DOI:10.1016/j.pharmthera.2021.107839.
[15] Markeli? I,Hlap?i$\check{\mathrm{C}}$ I,$\check{C}$eri A,et al.Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease[J].Sci Rep,2022,12(1):7544.DOI:10.1038/s41598-022-11164-1.
[16] Wu D,Wang X,Gao Y,et al.Shenqi Wenfei Formula alleviates chronic obstructive pulmonary disease in rats with pulmonary qi deficiency syndrome by regulating NLRP3/GSDMD pyroptosis pathway[J].J South Med Univ,2023,43(9):1500-1508.DOI:10.12122/j.issn.1673-4254.2023.09.07.
[17] Wu YX,Di X,Zhao M,et al.The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease[J].Immun Inflamm Dis,2022,10(12):e750.DOI:10.1002/iid3.750.
[18] Ma M,Li GY,Qi MH,et al.Inhibition of the inflammasome activity of NLRP3 attenuates HDM-Induced allergic asthma[J].Front Immunol,2021,12:718779.DOI:10.3389/fimmu.2021.718779.
[19] Xu WJ,Wang YM,Ma Y,et al.MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome[J].Respir Res,2020,21(1):116.DOI:10.1186/s12931-020-01374-4.
[20] Kalikkot Thekkeveedu R,Guaman MC,Shivanna B.Bronchopulmonary dysplasia:a review of pathogenesis and pathophysiology[J].Respir Med,2017,132:170-177.DOI:10.1016/j.rmed.2017.10.014.
[21] Shukla VV,Ambalavanan N.Recent advances in bronchopulmonary dysplasia[J].Indian J Pediatr,2021,88(7):690-695.DOI:10.1007/s12098-021-03766-w.
[22] Wang XY,Huo R,Liang ZJ,et al.Simvastatin inhibits NLRP3 inflammasome activation and ameliorates lung injury in hyperoxia-induced bronchopulmonary dysplasia via the KLF2-mediated mechanism[J].Oxid Med Cell Longev,2022,2022:8336070.DOI:10.1155/2022/8336070.
[23] Wang MR,Zhang F,Ning XM,et al.Regulating NLRP3 inflammasome-induced pyroptosis via Nrf2:TBHQ limits hyperoxia-induced lung injury in a mouse model of bronchopulmonary dysplasia[J].Inflammation,2023,46(6):2386-2401.DOI:10.1007/s10753-023-01885-4.
[24] Savin IA,Zenkova MA,Sen’kova AV.Pulmonary fibrosis as a result of acute lung inflammation:molecular mechanisms,relevant in vivo models,prognostic and therapeutic approaches[J].Int J Mol Sci,2022,23(23):14959.DOI:10.3390/ijms232314959.
[25] Cao W,Wang X,Li JL,et al.NLRP3 inflammasome activation determines the fibrogenic potential of PM2.5 air pollution particles in the lung[J].J Environ Sci (China),2022,111:429-441.DOI:10.1016/j.jes.2021.04.021.
[26] Liu JJ,Fan GQ,Tao NN,et al.Ginsenoside Rb1 alleviates bleomycin-induced pulmonary inflammation and fibrosis by suppressing central nucleotide-binding oligomerization-,leucine-rich repeat-,and pyrin domains-containing protein three inflammasome activation and the NF-κB pathway[J].Drug Des Devel Ther,2022,16:1793-1809.DOI:10.2147/DDDT.S361748.
[27] Zhou H,Zhang Q,Huang W,et al.NLRP3 inflammasome mediates silica-induced lung epithelial injury and aberrant regeneration in lung stem/progenitor cell-derived organotypic models[J].Int J Biol Sci,2023,19(6):1875-1893.DOI:10.7150/ijbs.80605.
[28] Mokrá D.Acute lung injury-from pathophysiology to treatment[J].Physiol Res,2020,69(Suppl 3):S353-S366.DOI:10.33549/physiolres.934602.
[29] Santa Cruz R,Villarejo F,Irrazabal C,et al.High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome[J].Cochrane Database Syst Rev,2021,3(3):CD009098.DOI:10.1002/14651858.CD009098.pub3.
[30] Tomazini BM,Maia IS,Cavalcanti AB,et al.Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19:the CoDEX randomized clinical trial[J].JAMA,2020,324(13):1307-1316.DOI:10.1001/jama.2020.17021.
[31] Liu T,Zhou Y,Li P,et al.Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation[J].Sci Rep,2016,6:39473.DOI:10.1038/srep39473.
[32] He YQ,Zhou CC,Yu LY,et al.Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms[J].Pharmacol Res,2021,163:105224.DOI:10.1016/j.phrs.2020.105224.
[33] Cai DS,Zhao Y,Yu F.Puerarin ameliorates acute lung injury by modulating NLRP3 inflammasome-induced pyroptosis[J].Cell Death Discov,2022,8(1):368.DOI:10.1038/s41420-022-01137-8.
[34] He Q,Hu D,Zheng FQ,et al.Investigating the nexus of NLRP3 inflammasomes and COVID-19 pathogenesis:unraveling molecular triggers and therapeutic strategies[J].Viruses,2024,16(2):213.DOI:10.3390/v16020213.
[35] Madurka I,Vishnevsky A,Soriano JB,et al.DFV890:a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function[J].Infection,2023,51(3):641-654.DOI:10.1007/s15010-022-01904-w.
[36] 上官雪娟,屈双权.儿童单肺通气研究进展[J].临床小儿外科杂志,2023,22(2):188-191.DOI:10.3760/cma.j.cn101785-202206049-017.Shangguan XJ,Qu SQ.Research advances of one-lung ventilation in children[J].J Clin Ped Sur,2023,22(2):188-191.DOI:10.3760/cma.j.cn101785-202206049ma.j.
[37] Luo GJ,Yao WF,He Y,et al.Ulinastatin prevents acute lung injury led by liver transplantation[J].J Surg Res,2015,193(2):841-848.DOI:10.1016/j.jss.2014.08.051.
[38] Hou L,Yang ZW,Wang ZK,et al.NLRP3/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1 secretion in acute lung injury induced by cardiopulmonary bypass[J].Lab Invest,2018,98(8):1052-1064.DOI:10.1038/s41374-018-0073-0.
[39] Sugasawa Y,Yamaguchi K,Kumakura S,et al.The effect of one-lung ventilation upon pulmonary inflammatory responses during lung resection[J].J Anesth,2011,25(2):170-177.DOI:10.1007/s00540-011-1100-0.

Memo

收稿日期:2023-11-30。
基金项目:湖南省自然科学基金面上项目(2023JJ30325)
通讯作者:屈双权,Email:shuangquanqu@126.com

Last Update: 1900-01-01